+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Excipient Market - Global Forecast 2026-2032- Product Image
Pharmaceutical Excipient Market - Global Forecast 2026-2032- Product Image
New

Pharmaceutical Excipient Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968715
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical excipient market is undergoing rapid transformation, increasingly recognized for its influence on therapeutic performance, regulatory adherence, and supply chain continuity. Senior decision-makers are facing converging priorities across innovation, compliance, and operational efficiency, making excipient strategy integral to industry leadership.

Market Snapshot: Pharmaceutical Excipient Market Size and Growth

The pharmaceutical excipient market is growing steadily, expanding from USD 11.36 billion in 2025 to USD 11.85 billion in 2026, with projections reaching USD 16.36 billion by 2032 at a CAGR of 5.34%. These figures reflect the critical role excipients now play in elevating drug effectiveness, ensuring formulation consistency, and addressing compliance in a regulated and cost-conscious landscape. Pharmaceutical excipients have evolved beyond support ingredients, now influencing product innovation, business strategies, and paths to market leadership.

Scope & Segmentation: Detailed Value Chain Coverage

  • Excipient Types: Includes inorganic excipients (like calcium carbonate, metal oxides, halites), a wide array of organic options (such as cellulose, starches, fatty alcohols, acrylic polymers, glycols), and protein-based alternatives, each presenting distinct challenges for formulation and sourcing.
  • Formulation Types: Encompasses oral, parenteral, and topical formulations, with additional focus on capsules, tablets, and liquid dosage forms. Each type demands unique excipient properties to optimize product performance.
  • Functional Categories: Covers binders, coatings, colorants, disintegrants, emulsifiers, fillers, flavoring agents, lubricants, preservatives, and agents for modifying viscosity, all aiming to enhance drug delivery and user experience.
  • End-User Segments: Serves biopharmaceutical companies, contract manufacturing organizations, pharmaceutical firms, and research laboratories, each with tailored needs for efficiency and compliance.
  • Distribution Models: Reflects both offline and online purchasing, with an increasing focus on digital platforms for improved inventory management and customer engagement.
  • Regional Coverage: Addresses the Americas, Europe, Middle East & Africa, and Asia-Pacific, highlighting that each region faces unique growth drivers, compliance environments, and sourcing demands.
  • Technology Integration: Showcases adoption of continuous manufacturing, 3D printing, advanced analytics, and digital twin modeling, supporting companies in meeting demand shifts, raising efficiency, and innovating in formulation.

Key Takeaways: Strategic Insights for Senior Leadership

  • Excipients are now strategic partners in drug development, playing active roles in therapeutic innovation and in designing products that address patient-centric demands.
  • Growing regulatory scrutiny heightens the need for transparent supply chains, stringent impurity standards, and moves toward sustainability, prompting investment in analytics and eco-conscious operations.
  • Innovation in excipient engineering is addressing increasingly complex formulation needs, using advanced morphologies and coatings to widen applicability across established and newly emerging therapy areas.
  • Regional dynamics strongly influence sourcing and innovation focus, with some markets prioritizing regulatory thoroughness and ingredient purity, while others drive progress through scale and adaptability.
  • The transition to digital procurement is enhancing visibility, flexibility, and cost control, helping companies better manage inventory and respond to supply challenges within the excipient value chain.
  • Targeted partnerships, proprietary technology platforms, and strategic acquisitions are enabling suppliers to capture emerging opportunities and align portfolios closely with evolving customer requirements.

Tariff Impact: Adjusting to US Import Changes

Forthcoming US tariff changes set for 2025 will impact international excipient supply chains, introducing higher duties on certain inorganic and organic raw materials. In response, manufacturers are re-evaluating supplier diversity, exploring alternative sourcing, and renegotiating contracts to contain operational costs. Steps such as vertical integration and domestic processing are under consideration to safeguard profit margins and mitigate exposure. Additionally, companies are re-examining formulation strategies—potentially substituting or reformulating excipients in-house—to lessen tariff-driven disruptions and strengthen risk management frameworks.

Methodology & Data Sources

This research applies a multi-phase methodology, combining insights from interviews with formulation scientists, regulatory experts, and supply chain professionals, with extensive secondary research across regulatory, technical, and industry publications. All findings are validated through triangulation and expert peer review for precision and industry relevance.

Why This Report Matters

  • Provides senior executives with comprehensive insight into pharmaceutical excipients to support confident decisions in investment, sourcing, and compliance strategies.
  • Highlights intersections of sustainability, regulatory demands, and digital transformation to help organizations adapt proactively.
  • Enables scenario planning and effective risk management as tariffs evolve, value chains become more complex, and end-user requirements shift.

Conclusion

Strategic investment in innovation, robust compliance, and operational agility positions leaders to increase supply resilience and discover growth prospects in the evolving pharmaceutical excipient market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Pharmaceutical Excipient Market, by Type
8.1. Inorganic
8.1.1. Calcium Carbonate
8.1.2. Calcium Phosphate
8.1.3. Calcium Sulfate
8.1.4. Halites
8.1.5. Metal Oxides
8.2. Organic
8.2.1. Carbohydrates
8.2.1.1. Cellulose
8.2.1.2. Starch
8.2.1.3. Sugars
8.2.2. Oleochemicals
8.2.2.1. Fatty Alcohols
8.2.2.2. Glycerin
8.2.2.3. Mineral Stearates
8.2.3. Petrochemicals
8.2.3.1. Acrylic Polymers
8.2.3.2. Glycols
8.2.3.3. Mineral Hydrocarbons
8.2.3.4. Povidones
8.2.4. Proteins
9. Pharmaceutical Excipient Market, by Formulation
9.1. Oral Formulations
9.1.1. Hard Gelatin Capsules
9.1.2. Liquid Formulations
9.1.3. Soft Gelatin Capsules
9.1.4. Tablets
9.2. Parenteral Formulations
9.3. Topical Formulations
10. Pharmaceutical Excipient Market, by Function
10.1. Binders
10.2. Coating Agents
10.3. Colorants
10.4. Disintegrants
10.5. Emulsifying Agents
10.6. Fillers & Diluents
10.7. Flavoring Agents & Sweeteners
10.8. Lubricants & Glidants
10.9. Preservatives
10.10. Suspending & Viscosity Agents
11. Pharmaceutical Excipient Market, by End-User
11.1. Biopharmaceutical Companies
11.2. Contract Manufacturing Organizations
11.3. Pharmaceutical Companies
11.4. Research Laboratories
12. Pharmaceutical Excipient Market, by Distribution Channel
12.1. Offline
12.2. Online
13. Pharmaceutical Excipient Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Pharmaceutical Excipient Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Pharmaceutical Excipient Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Pharmaceutical Excipient Market
17. China Pharmaceutical Excipient Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. ABITEC Corporation
18.6. Actylis
18.7. Archer Daniels Midland Company
18.8. ARMOR PROTEINES S.A.S. by Savencia Group
18.9. Asahi Kasei Corporation
18.10. Ashland Inc.
18.11. BASF SE
18.12. BIOGRUND GmbH
18.13. Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG
18.14. Clariant AG
18.15. Colorcon Inc.
18.16. Corel Pharma Chem Private Limited
18.17. Croda International Plc
18.18. Darling Ingredients, Inc.
18.19. DFE Pharma GmbH & Co KG by Royal FrieslandCampina N.V.
18.20. DuPont de Nemours, Inc.
18.21. Evonik Industries AG
18.22. Fuji Chemical Industries Co., Ltd.
18.23. GATTEFOSSE SAS
18.24. Innophos Holdings, Inc. by Iris Parent LLC
18.25. International Flavors & Fragrances Inc.
18.26. JRS PHARMA GmbH + Co. KG
18.27. Kerry Group P.L.C.
18.28. Lipoid GmbH
18.29. Lubrizol Corporation
18.30. L’AIR LIQUIDE S.A.
18.31. Mallinckrodt plc
18.32. MEGGLE GmbH & Co. KG
18.33. Merck KGaA
18.34. Nagase & Co., Ltd.
18.35. Nipon Soda Co., Ltd.
18.36. NOF Corporation
18.37. Omya International AG
18.38. Peter Greven GmbH & Co. KG
18.39. Roquette Frères S.A.
18.40. Shin-Etsu Chemical Co., Ltd.
18.41. Solvay S.A.
18.42. SPI Pharma, Inc.
18.43. Sumitomo Seika Chemicals Company, Limited
18.44. Thermo Fisher Scientific Inc.
18.45. Vanderbilt Minerals LLC
List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 157. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 194. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 196. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 197. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 198. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 199. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 200. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 201. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 202. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 203. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 204. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 205. EUROPE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 218. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 220. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 221. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 222. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 223. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 224. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 225. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 226. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 227. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 228. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 229. AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 242. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 243. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 245. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 246. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 247. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 248. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 249. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 250. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 251. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 252. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 253. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 254. ASEAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 255. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 257. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 258. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 259. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 260. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 261. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 262. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 263. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 264. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 265. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 266. GCC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 279. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 281. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 282. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 283. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 284. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 285. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 286. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 287. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 288. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 289. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 290. BRICS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 291. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 292. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 293. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 294. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 295. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 296. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 297. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 298. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 299. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 300. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 301. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 302. G7 PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 303. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 304. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 305. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2032 (USD MILLION)
TABLE 306. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2032 (USD MILLION)
TABLE 307. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2032 (USD MILLION)
TABLE 308. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2032 (USD MILLION)
TABLE 309. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2032 (USD MILLION)
TABLE 310. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 311. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2032 (USD MILLION)
TABLE 312. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2032 (USD MILLION)
TABLE 313. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 314. NATO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 315. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 316. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 317. UNITED STATES PHARMACEUTICAL

Companies Mentioned

The key companies profiled in this Pharmaceutical Excipient market report include:
  • ABITEC Corporation
  • Actylis
  • Archer Daniels Midland Company
  • ARMOR PROTEINES S.A.S. by Savencia Group
  • Asahi Kasei Corporation
  • Ashland Inc.
  • BASF SE
  • BIOGRUND GmbH
  • Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG
  • Clariant AG
  • Colorcon Inc.
  • Corel Pharma Chem Private Limited
  • Croda International Plc
  • Darling Ingredients, Inc.
  • DFE Pharma GmbH & Co KG by Royal FrieslandCampina N.V.
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • GATTEFOSSE SAS
  • Innophos Holdings, Inc. by Iris Parent LLC
  • International Flavors & Fragrances Inc.
  • JRS PHARMA GmbH + Co. KG
  • Kerry Group P.L.C.
  • Lipoid GmbH
  • Lubrizol Corporation
  • L’AIR LIQUIDE S.A.
  • Mallinckrodt plc
  • MEGGLE GmbH & Co. KG
  • Merck KGaA
  • Nagase & Co., Ltd.
  • Nipon Soda Co., Ltd.
  • NOF Corporation
  • Omya International AG
  • Peter Greven GmbH & Co. KG
  • Roquette Frères S.A.
  • Shin-Etsu Chemical Co., Ltd.
  • Solvay S.A.
  • SPI Pharma, Inc.
  • Sumitomo Seika Chemicals Company, Limited
  • Thermo Fisher Scientific Inc.
  • Vanderbilt Minerals LLC

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.85 Billion
Forecasted Market Value ( USD ) by 2032 $ 16.36 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned42

Related Topics

Related Reports

Organic Pharmaceutical Excipients Market - Global Forecast 2026-2032 - Product Image

Organic Pharmaceutical Excipients Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Nutraceutical Excipients Market - Global Forecast 2026-2032 - Product Image

Nutraceutical Excipients Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Pharmaceutical Excipients Market by Product ((Organic (Oleochemicals, Cellulose, Glycols), Inorganic)), Functionality (Fillers & Diluents, Binders, Lubricants), Formulation (Oral, Parenteral), Functionality Application (Stabilizers) - Global Forecast to 2030 - Product Image

Pharmaceutical Excipients Market by Product ((Organic (Oleochemicals, Cellulose, Glycols), Inorganic)), Functionality (Fillers & Diluents, Binders, Lubricants), Formulation (Oral, Parenteral), Functionality Application (Stabilizers) - Global Forecast to 2030

  • Report
  • 633 Pages
  • Global
From
2025 Pharmaceutical Excipients Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Image

2025 Pharmaceutical Excipients Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • 155 Pages
  • Global
From
2025 Alcohol Excipients Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Image

2025 Alcohol Excipients Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • 153 Pages
  • Global
From

About the Drug Excipient Market

The Drug Excipient market is an important part of the Pharmaceutical industry. Drug Excipients are inactive ingredients used in the production of drugs and medications. They are used to bind, fill, dissolve, stabilize, and protect the active ingredients in a drug. Excipients are also used to improve the taste, texture, and appearance of a drug. Excipients are essential components of any drug formulation, as they can affect the safety, efficacy, and stability of the drug. The Drug Excipient market is highly competitive, with many companies offering a wide range of products. Companies in the market include BASF, Roquette, Ashland, Colorcon, Evonik, and Dow. These companies provide a variety of excipients, including fillers, binders, lubricants, disintegrants, glidants, and stabilizers. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.